Reported results
- Net sales were $940.5 million, compared to $942.5 million in the third quarter of 2025.
- Net earnings were $126.3 million, compared to $132.0 million in the third quarter of 2025.
- Diluted earnings per share (GAAP) were $0.93, compared to $0.94 in the third quarter of 2025.
- North America segment sales were $761.6 million, with an adjusted North America segment margin (non-GAAP) of 23.6%.
- Rest of World segment sales were $192.8 million, with segment earnings of $10.5 million.
- Free cash flow (non-GAAP) for the first nine months of 2026 was $396.2 million.
Guidance
- 2026 full year net sales growth, excluding China, of approximately 4%
- 2026 full year adjusted EPS (non-GAAP), excluding China, of between $3.42 and $3.52
Notes
The Company expects to classify the China business as held for sale and report it as discontinued operations beginning in the fourth quarter of 2026; 2026 full-year guidance excludes the China business and approximately $20 million in North America water treatment estimated pre-tax restructuring and impairment expenses.
Price and volatility reaction
The stock moved +4.3% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -4.0 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 60.4957 | 2026-10-28 |
| Close after release | 63.11 | 2026-10-29 |
| Realised move | +4.3% | close to close |
| 30d ATM IV change | -4.0 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-29 (8-K, Item 2.02). Read the original filing on sec.gov.
